to page content
to site navigation
The Foundation's primary site.
Global news, events, and resources.
The national learning program for entrepreneurs.
A new approach to developing the next generation of high-growth firms.
Access to university research and innovation.
The Kauffman Foundation's charter school serving Kansas City.
Encouraging the aspirations of young people.
The platform for business plan competitions.
College preparation and access for urban youth in Kansas City.
A guide to Kauffman Foundation and partner resources, for aspiring entrepreneurs.
News and announcements from the Foundation.
From our vice president of Entrepreneurship.
From our vice president of Advancing Innovation.
News from Global Entrepreneurship Week
News about this education program for entrepreneurs.
Tweets for the eMed Community at Entrepreneurship.org
News from the Kauffman Labs program.
From our business plan competition service.
Contribute to the community seeking to improve entrepreneurship and innovation measurement.
A look at entrepreneurship from the Kauffman Foundation's Thom Ruhe.
Tracks research and policies that are accelerating economic growth and changing the world.
Brings to light various policies and initiatives to advance innovation and drive economic growth.
A selection of our videos
Take our video and audio with you.
Explore many of our publications.
Join the discussion on our LinkedIn site.
Join us on Google's social service.
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Dr. John Hennessy has been President of Stanford University since 2000. He became a Stanford faculty member in 1977. He rose through the academic ranks to full professorship in 1986 and was the inaugural Willard R. and Inez Kerr Bell Professor of Electrical Engineering and Computer Science from 1987 to 2004. A pioneer in computer architecture, in 1981 Dr. Hennessy drew together researchers to focus on a computer architecture known as RISC (Reduced Instruction Set Computer), a technology that has revolutionized the computer industry by increasing performance while reducing costs. In 1984, he used his sabbatical year to found MIPS Computer Systems Inc. to commercialize his research in RISC processors. Dr. Hennessy is a recipient of the 2000 IEEE John von Neumann Medal, a 2004 NEC C&C Prize for lifetime achievement in computer science and engineering, and a 2005 Founders Award from the American Academy of Arts and Sciences. Dr. Hennessy earned his bachelor's degree in electrical engineering from Villanova University and his master's and doctoral degrees in computer science from the State University of New York at Stony Brook.
Elizabeth A. Holmes is President and Chief Executive Officer of Theranos, Inc. Holmes left Stanford University in 2003 at the age of 19 to pursue her company, and she successfully raised $6 million in venture capital from many firms, including Draper Fisher Jurvetson. Holmes' unique background in microfluidics and nanotechnology led her to found Theranos based on her patent, Medical Device for Analyte Monitoring and Drug Release. The invention and the company are based on her vision to create a new sector of personalized health care that enables individuals to take control of their health through real-time diagnosis, monitoring, and non-invasive treatment of targeted ailments. She took the company from concept to reality, building a management team and leading the product and commercial development infrastructures. Previous to Theranos, while Holmes was still in high school, she started a business to distribute C++ software to Asian universities. Holmes has also worked for Genencor International, the Genome Institute Singapore, and she?s acted as Executive Director of Stanford University's Asia Technology Initiative.
Paul Yock interviews Howard Holstein, regulatory attorney, on 510(k) vs. PMA regulatory strategies.
Paul Yock interviews Howard Holstein, regulatory attorney, on investigational device exemptions.
Paul Yock interviews Howard Holstein, regulatory attorney, discussing some regulatory case studies.
Paul Yock interviews Howard Holstein, regulatory attorney, on understanding the FDA.
Jeffrey Housenbold is President & CEO of Shutterfly, Inc., an internet-based social expression and personal publishing service. Shutterfly provides a full range of products and services that enable consumers to manage their digital photographs. Housenbold has a successful track record of building online consumer franchises by combining commerce and community. In June 2006, he received the Ernst & Young Entrepreneur of the Year Award in the Retail and Consumer Products category for the Northern California region. Previously, Housenbold was Vice President of Business Development & Internet Marketing at eBay, where he managed customer acquisition and retention. At eBay he also held positions as Vice President & General Manager of its Business-to-Consumer Group and Vice President of Mergers and Acquisitions. Formerly, he held senior management positions with AltaVista, including Vice President & General Manager, and was the Chief Operating Officer of Raging Bull, the community finance portal. He also served as Vice President of Corporate Development at WinStar Communications and as Manager and Founder of Accenture's Media & Entertainment Strategy Group. Housenbold completed his undergraduate degree with High Honors at Carnegie Mellon University in Economics and Business Administration and was also a Presidential Scholar. He went on to earn his MBA from Harvard Business School where he was a Dean's Fellow. Housenbold is the co-author of The Shutterfly Guide to Great Digital Photos, an instructional book published by McGraw-Hill on the essentials of digital photography and managing images. He is an avid photographer with his Canon 30D.
Jen-Hsun Huang co-founded NVIDIA Corporation in April 1993 and has served as President, Chief Executive Officer, and a member of the Board of Directors since its inception. Under his leadership, NVIDIA has become one of the largest fabless semiconductor companies in the world. NVIDIA has received numerous business and technology awards during Mr. Huang's tenure, including Fortune's Fastest Growing Companies, Wired Magazine's Top 40, and Stanford Business School's Entrepreneurial Company of the Year. Mr. Huang has served as on the Board of Trustees of the RAND Corporation since 1999 and is often invited to speak on technology and business trends at industry events. Prior to founding NVIDIA, Mr. Huang was Director of Coreware at LSI Logic and a microprocessor designer at Advanced Micro Devices. Mr. Huang holds a B.S.E.E. degree from Oregon State University and an M.S.E.E. degree from Stanford University.
Mir Imran founded InCube Laboratories in 1995 to focus on his passion: creating medical device solutions that change the standard of care in critical healthcare markets. Mir began his career as a med-tech entrepreneur in the late 1970's. Over the decades, he has become one of the world's most successful inventors, entrepreneurs and investors in healthcare. Mir now holds more than 200 issued patents - and is perhaps most well known for his pioneering contributions to the first FDA-approved Automatic Implantable Cardioverter Defibrillator. Mir's current crop of inventions includes advanced treatments for neural aneurysms, epilepsy, ulcerative colitis, obesity and chronic pain, among others. Most of these will enter clinical trials in the 2008 to 2010 timeframe. As an entrepreneur, Mir has founded over 20 medical device companies, including: Vidamed (acquired by Medtronic), Physiometrix, Cardiac Pathways, Advanced Cytomextrix (acquired by Oncotech 1997), Percusurge (acquired by Medtronic 2001), Reflow, Inc. (acquired 1999), Safeview (acquired by L3 2006) Intrapace (founded 2001), Spinal Modulation (founded 2005) and Zonare (founded 1999). As an investor, Mir serves as the Life Science Venture Partner for DFJ ePlanet, where he has led 9 investments in a range of promising ventures around the globe. Mir is also an active angel investor, with a portfolio based around both medical and pharmaceutical ventures. Mir currently holds board seats with Bodymedia, Cardiovasc, Intrapace, Egeen International, Spinal Modulation, ZARS and Zonare. Mir holds an MS in Bio-Engineering and a BS in Electrical Engineering from Rutgers, where he spent three years as a Research Specialist.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.
